Literature DB >> 580372

Distribution and excretion of the mercury chelating agent sodium 2,3-dimercaptopropane-1-sulfonate in the rat.

B Gabard.   

Abstract

The distribution and excretion of sodium 2,3-dimercapto-1,3 14C-propane-1-sulfonate as dependent on time has been studied in the rat. The highest concentration is found in the kidneys, the lowest in the brain. The excretion is very rapid (T1/2 = 19 min) and follows a monoexponential curve during the first hour after administration. This holds for plasma and most of the organs too. The apparent distribution volume of the radioactivity is equivalent to the volume of the extracellular water. After oral administration, 30-40% is absorbed from the gut. The results lead to the conclusion that a fraction of the drug is weakly bound to plasma- and membrane-proteins. They are discussed with respect to the treatment of heavy metal poisoning.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 580372     DOI: 10.1007/bf00296388

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  15 in total

1.  [Conversion of unithiol in the organism].

Authors:  N I LUGANSKII; Iu I LOBODA
Journal:  Farmakol Toksikol       Date:  1960 Jul-Aug

2.  [Glomerular clearance, p-aminohippuric acid clearance and diuresis in various forms of diuresis in non-anesthetized rats].

Authors:  G PETERS
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1959

3.  Treatment of methylmercury poisoning in the rat with sodium 2,3-dimercaptopropane-i-sulfonate: influence of dose and mode of administration.

Authors:  B Gabard
Journal:  Toxicol Appl Pharmacol       Date:  1976-11       Impact factor: 4.219

4.  Passive permeabilities of luminal and basolateral membranes in the isolated mucosal epithelium of guinea pig small intestine.

Authors:  F Lauterbach
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-04       Impact factor: 3.000

5.  The excretion and distribution of inorganic mercury in the rat as influenced by several chelating agents.

Authors:  B Gabard
Journal:  Arch Toxicol       Date:  1976-01-30       Impact factor: 5.153

6.  Use of unithiol for reducing radiation hazard of renal scintigraphy with chlormerodrin 203Hg. I. Estimation of the urinary excretion of 203Hg.

Authors:  M Ogiński; K Kloczkowski
Journal:  Int Urol Nephrol       Date:  1973       Impact factor: 2.370

7.  Use of unithiol for reducing radiation hazard of renal scintigraphy with chlormerodrin 203Hg. II. Scintigraphic estimation.

Authors:  K Kloczkowski; M Ogiński
Journal:  Int Urol Nephrol       Date:  1973       Impact factor: 2.370

8.  [New immobilization cage for studies of metabolism in the rat].

Authors:  V Volf; T Mohr
Journal:  Z Versuchstierkd       Date:  1971

9.  Chelating therapy with Na-DMS in occupational lead and mercury intoxications.

Authors:  S C Wang; K S Ting; C C Wu
Journal:  Chin Med J       Date:  1965-07

10.  [Dislocation and excretion of mercury in rats following application of unithiol].

Authors:  T Dutkiewicz; M Ogiński
Journal:  Int Arch Arbeitsmed       Date:  1967
View more
  11 in total

1.  Analysis of animal pharmacokinetic data: performance of the one point per animal design.

Authors:  E I Ette; A W Kelman; C A Howie; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

Review 2.  2,3-Dimercapto-1-propanesulphonate in heavy metal poisoning.

Authors:  K Hruby; A Donner
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

3.  [Suicide by intravenous injection of sublimate solution].

Authors:  V Dittmann; O Pribilla
Journal:  Z Rechtsmed       Date:  1985

4.  Chelation of lead with DMPS and BAL in rats injected with lead.

Authors:  T A Twarog; M G Cherian
Journal:  Bull Environ Contam Toxicol       Date:  1983-02       Impact factor: 2.151

5.  Pitfalls and valid approaches to pharmacokinetic analysis of mean concentration data following intravenous administration.

Authors:  D M Cocchetto; W A Wargin; J W Crow
Journal:  J Pharmacokinet Biopharm       Date:  1980-12

6.  Subchronic treatment with sodium 2,3-dimercaptopropane-1-sulfonate in methylmercury poisoning.

Authors:  S G Schäfer; M Storp; E Richter
Journal:  Bull Environ Contam Toxicol       Date:  1982-10       Impact factor: 2.151

7.  Removal of internally deposited gold by 2,3-dimercaptopropane sodium sulphonate (Dimaval).

Authors:  B Gabard
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

8.  Mobilized mercury in subjects with varying exposure to elemental mercury vapour.

Authors:  M Molin; A Schütz; S Skerfving; G Sällsten
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

9.  Enhancement of the kidney Cd burden by SH-containing chelating agents.

Authors:  W Rau; F Planas-Bohne
Journal:  Biol Trace Elem Res       Date:  1989 Jul-Sep       Impact factor: 3.738

10.  Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite.

Authors:  Laura-Oana Albulescu; Melissa S Hale; Stuart Ainsworth; Jaffer Alsolaiss; Edouard Crittenden; Juan J Calvete; Chloe Evans; Mark C Wilkinson; Robert A Harrison; Jeroen Kool; Nicholas R Casewell
Journal:  Sci Transl Med       Date:  2020-05-06       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.